Letter: loss of response to anti-TNFα agents depends on treatment duration in patients with inflammatory bowel disease—authors' reply

Remi Mahmoud, Johannes P.D. Schultheiss, Herma H. Fidder, Bas Oldenburg*

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)499-500
Number of pages2
JournalAlimentary Pharmacology and Therapeutics
Volume55
Issue number4
DOIs
Publication statusPublished - Feb 2022

Keywords

  • Chronic Disease
  • Duration of Therapy
  • Humans
  • Inflammatory Bowel Diseases/drug therapy

Cite this